Drug intelligence / Profile preview

bromhexine + guaifenesin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Bromhexine + guaifenesin is an oral fixed-dose combination of the mucolytic agent bromhexine and the expectorant guaifenesin, used for the symptomatic treatment of productive (chesty) cough and respiratory conditions characterized by excessive, viscous mucus such as acute and chronic bronchitis and other bronchopulmonary disorders.[2][3][8][9] Bromhexine depolymerizes and thins mucopolysaccharide fibers in bronchial secretions, reducing mucus viscosity and facilitating ciliary clearance, while guaifenesin increases the volume and decreases the adhesiveness and surface tension of bronchial secretions, making mucus easier to mobilize and expectorate.[2][3][4][9] Together, this small‑molecule combination enhances mucociliary clearance and converts unproductive cough into a more productive one without opioid-induced sedation, and is marketed in multiple countries in various over-the-counter and prescription cough and cold products, particularly as syrups and oral liquids.[2][3][8][9]

Brand names
Chesty Cough ForteDuro-Tuss Chesty Cough Liquid ForteDimetapp Chesty Cough ElixirChemists’ Own Chesty Cough oral liquid
02

Targets

CHRM3 (M3)NMDAR (Glutamate receptor ionotropic, NMDA)TMPRSS2 (Transmembrane protease serine 2)

Beyond the preview

Go deeper on bromhexine + guaifenesin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bromhexine + guaifenesin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call